[
    {
        "outcome_uid": "cd979f9b",
        "clinical_question": "Should patients with MTX-na\u00efve and non-MTX csDMARDs na\u00efve RA and low disease activity receive MTX monotherapy or an alternative csDMARD monotherapy?",
        "population": "Patients with MTX-na\u00efve and non-MTX csDMARDs na\u00efve RA and low disease activity",
        "intervention": "MTX monotherapy",
        "comparator": "LEF",
        "outcome": "Disease activity (follow up: 6 months; assessed with: DAS28-ESR (Lower values \u2013 > benefit) (MCID -1.17)",
        "importance": "CRITICAL",
        "related_paper_list": [
            "fa180e46"
        ],
        "assessment_results": {
            "GRADE": {
                "Risk of bias": {
                    "result": "VERY_SERIOUS",
                    "rationales": "Downgraded by one level due to serious risk of bias. Lack of allocation concealment and lack of blinding of patients, personnel, and outcome assessors."
                },
                "Inconsistency": {
                    "result": "NOT_SERIOUS",
                    "rationales": ""
                },
                "Indirectness": {
                    "result": "SERIOUS",
                    "rationales": "Downgraded by one level due to serious indirectness. The evidence is based on a population with moderate to high disease activity."
                },
                "Imprecision": {
                    "result": "NOT_SERIOUS",
                    "rationales": ""
                },
                "Other considerations": {
                    "result": "none",
                    "rationales": ""
                },
                "Study design": "Randomized Controlled Trial",
                "Certainty": "LOW",
                "No of participants": {
                    "MTX monotherapy": "147",
                    "LEF": "147"
                },
                "Annotation": {},
                "Effect": {
                    "Relative Effect (95% CI)": "-",
                    "Absolute Effect (95% CI)": "MD 0.1 lower (0.27 lower to 0.07 higher)",
                    "Abbreviations": "CI: Confidence interval; RR: Risk ratio; MD: Mean difference; HR: Hazard Ratio"
                }
            }
        }
    }
]